Cognitive effects with rivastigmine augmentation of risperidone: A 12-month, randomized, double-blind, placebo-controlled study in schizophrenia

OBJECTIVE: An important challenge in schizophrenia therapeutics is to develop an efficacious treatment for cognitive impairment. Acetylcholinesterase inhibitors, such as rivastigmine, have been studied for improving cognitive performance in these patients. MATERIALS AND METHODS: Rivastigmine (uptitr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Pattath Narayanan Suresh, Mohemmedali, Seema P., Anish, P. K., Andrade, Chittaranjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547865/
https://www.ncbi.nlm.nih.gov/pubmed/28827871
http://dx.doi.org/10.4103/psychiatry.IndianJPsychiatry_133_16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547865/
https://www.ncbi.nlm.nih.gov/pubmed/28827871
http://dx.doi.org/10.4103/psychiatry.IndianJPsychiatry_133_16

Ejemplares similares